SCHEMBL932347

SCHEMBL932347

CCCCCCCCCCCCCCCCCCC(CCCCCCCCCCCCCCCC)C(=O)OC(=O)CCCCCCCCCCCCCCCCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.55
LMNA P02545 4/20 0.52
MAPT P10636 2/20 0.51
PAM P19021 2/20 0.50
ALDH1A1 P00352 1/20 0.50
KDM4E B2RXH2 1/20 0.49
DUSP3 P51452 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
MAPK1 P28482 1/20 0.49
TSHR P16473 2/20 0.47
CA2 P00918 1/20 0.47
PRKCA P17252 1/20 0.46
PRKCE Q02156 1/20 0.46
PRKCQ Q04759 1/20 0.46
PRKCD Q05655 1/20 0.46
DNM1 Q05193 1/20 0.46
CYP3A4 P08684 1/20 0.46
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849680 1.00 DGKA (0.55) DGKALMNAMAPTPAMALDH1A1
SCHEMBL20394158 1.00 DGKA (0.55) DGKALMNAMAPTPAMALDH1A1
SCHEMBL1761020 1.00 DGKA (0.55) DGKALMNAMAPTPAMALDH1A1
SCHEMBL3075652 1.00 DGKA (0.55) DGKALMNAMAPTPAMALDH1A1
SCHEMBL20394156 1.00 DGKA (0.55) DGKALMNAMAPTPAMALDH1A1
SCHEMBL21409708 1.00 DGKA (0.55) DGKALMNAMAPTPAMALDH1A1
SCHEMBL20394142 1.00 DGKA (0.55) DGKALMNAMAPTPAMALDH1A1
SCHEMBL20394140 1.00 DGKA (0.55) DGKALMNAMAPTPAMALDH1A1
SCHEMBL20394164 1.00 DGKA (0.55) DGKALMNAMAPTPAMALDH1A1
SCHEMBL1173129 1.00 DGKA (0.55) DGKALMNAMAPTPAMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0805184-B1 Polycarbonate compositions having mold-release properties BAYER AG (US) 2005-08-31 EP claimed
US-20020155962-A1 Nonaqueous hair styling composition and method of use ANDREW JERGENS COMPANY, THE 2002-10-24 US claimed
US-5856413-A COMPLEX ESTER SUCH AS STEARYL STEAROYLSTEARATE BAYER CORPORATION (US) 1999-01-05 US claimed
EP-0805184-A2 Polycarbonate compositions having mold-release properties Bayer Corporation (US) 1997-11-05 EP claimed
US-20230265268-A1 THERMOPLASTIC ELASTOMER COMPOSITION POLYMAX THERMOPLASTIC ELASTOMERS, LLC 2023-08-24 US disclosed
US-20230157299-A1 DISPENSABLE NANOPARTICLE BASED COMPOSITION FOR DISINFECTION KISMET TECHNOLOGIES INC. 2023-05-25 US disclosed
EP-4125364-A1 DISPENSABLE NANOPARTICLE BASED COMPOSITION FOR DISINFECTION University of Central Florida Research Foundation, Inc. (US) 2023-02-08 EP disclosed
WO-2021222779-A1 DISPENSABLE NANOPARTICLE BASED COMPOSITION FOR DISINFECTION UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2021-11-04 WO disclosed
EP-2701670-B1 CLEAR WET SUN-CARE SPRAYS AND GELS ISP INVESTMENTS LLC (US) 2021-10-20 EP disclosed
US-20210000714-A1 ALCOHOL-BASED HAND CONDITIONERS FOR REPEATED USE GOJO INDUSTRIES, INC. 2021-01-07 US disclosed
EP-3758670-A1 ALCOHOL-BASED HAND CONDITIONERS FOR REPEATED USE Gojo Industries, Inc. (US) 2021-01-06 EP disclosed
US-10850135-B2 Antiseptic-tolerant lactic acid bacteria AB-BIOTICS, S.A. (ES) 2020-12-01 US disclosed
US-5856413-A COMPLEX ESTER SUCH AS STEARYL STEAROYLSTEARATE BAYER CORPORATION (US) 1999-01-05 US disclosed
EP-0805184-A2 Polycarbonate compositions having mold-release properties Bayer Corporation (US) 1997-11-05 EP disclosed
EP-0338565-B1 N-Alkoxyalkylamides of hydroxyacids and skin treating compositions therewith REVLON CONSUMER PROD CORP (US) 1994-08-10 EP disclosed
EP-0386127-A1 ALCOHOL FREE - LIQUID MAKEUP COMPOSITION PLOUGH, INC. (US) 1990-09-12 EP disclosed
EP-0366753-A4 N-ALKOXYALKYLAMIDES AND COSMETIC TREATING COMPOSITIONS THEREWITH. REVLON (US) 1990-06-27 EP disclosed
EP-0366753-A1 N-ALKOXYALKYLAMIDES AND COSMETIC TREATING COMPOSITIONS THEREWITH REVLON, INC. (US) 1990-05-09 EP disclosed
WO-1989010121-A1 N-ALKOXYALKYLAMIDES AND COSMETIC TREATING COMPOSITIONS THEREWITH REVLON, INC. (US) 1989-11-02 WO disclosed
WO-1989004652-A1 ALCOHOL FREE - LIQUID MAKEUP COMPOSITION PLOUGH, INC. (US) 1989-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230157299-A1 DISPENSABLE NANOPARTICLE BASED COMPOSITION FOR DISINFECTION DSTN, CD63, EXOSC9 DGKA 325/4885LMNA 3155/4885MAPT 4445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.